Hans Ericsson

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Tyrosine Kinase

Chronic Obstructive Pulmonary Disease

Heart Rate Variability

Top Venues

British journal of clinical pharmacology

Pharmacology research & perspectives

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Jane Knöchel, Vijender Panduga, Karin Nelander, Maria Heijer, Eva-Lotte Lindstedt, Hodan Ali, Malin Aurell, Helena Ödesjö, Pablo Forte, Kat Connolly, Hans Ericsson, Iain MacPhee
A drug-drug interaction study and physiologically based pharmacokinetic modelling to assess the effect of an oral 5-lipoxygenase activating protein inhibitor on the pharmacokinetics of oral midazolam. British journal of clinical pharmacology 90 (9) (2024)
Chandrali S Bhattacharya, Patricia Ely Pizzato, Maria Heijer, Mikael Sunnåker, Julie Holden, Monika Trebski, Karin Nelander, Hodan Ali, Diyan K Genov, Malin Aurell, Anna Collén, Hans Ericsson
The effect of severe renal impairment on the pharmacokinetics, safety and tolerability of mitiperstat. British journal of clinical pharmacology (2024)
Joanna Parkinson, Jesper Sundell, Dinko Rekić, Karin Nelander, Hans Ericsson, Ahmad Ebrahimi, Corina Dota, Mikael Sunnåker
The myeloperoxidase inhibitor mitiperstat (AZD4831) does not prolong the QT interval at expected therapeutic doses. Pharmacology research & perspectives 12 (2) (2024)
Joanna Parkinson, Jesper Sundell, Dinko Rekić, Karin Nelander, Hans Ericsson, Ahmad Ebrahimi, Corina Dota, Mikael Sunnåker
The myeloperoxidase inhibitor mitiperstat (AZD4831) does not prolong the QT interval at expected therapeutic doses. Pharmacology research & perspectives 12 (2) (2024)
Jane Knöchel, Vijender Panduga, Karin Nelander, Maria Heijer, Eva-Lotte Lindstedt, Hodan Ali, Malin Aurell, Helena Ödesjö, Pablo Forte, Kat Connolly, Hans Ericsson, Iain MacPhee
A drug-drug interaction study and physiologically based pharmacokinetic modelling to assess the effect of an oral 5-lipoxygenase activating protein inhibitor on the pharmacokinetics of oral midazolam. British journal of clinical pharmacology (2024)
Jane Knöchel, Vijender Panduga, Karin Nelander, Maria Heijer, Eva-Lotte Lindstedt, Hodan Ali, Malin Aurell, Helena Ödesjö, Pablo Forte, Kat Connolly, Hans Ericsson, Iain MacPhee
A drug-drug interaction study and physiologically based pharmacokinetic modelling to assess the effect of an oral 5-lipoxygenase activating protein inhibitor on the pharmacokinetics of oral midazolam. British journal of clinical pharmacology 90 (9) (2024)
Karin Nelander, Maria Lagerstrom-Fermer, Carl Amilon, Erik Michaëlsson, Maria Heijer, Magnus Kjaer, Muir Russell, David Han, Eva-Lotte Lindstedt, Carl Whatling, Li-Ming Gan, Hans Ericsson
Early Clinical Experience With AZD4831, A Novel Myeloperoxidase Inhibitor, Developed for Patients With Heart Failure With Preserved Ejection Fraction. Clinical and translational science 14 (3) (2021)